Printer Friendly
The Free Library
14,506,428 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Elekta AB reports six month financial results.


STOCKHOLM Stockholm (stŏk`hôlm'), city (1995 pop. 692,954), capital of Sweden and of Stockholm co., E Sweden, situated where Lake Mälaren flows into the Baltic Sea. , Sweden--(BUSINESS WIRE)--Dec. 13, 1994--
                     SIX MONTH INTERIM REPORT
                     May 1 - October 31, 1994


o Revenues rose by 37 percent,

primarily through introduction of new products and volume

growth.

o Operating results increased by 125 percent to SEK SEK

In currencies, this is the abbreviation for the Swedish Krona.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 34.2

million.

o Earnings per share rose by 45 percent

and it amounted to SEK 3.98, despite the increase of 31

percent in the number of shares.

o New products were launched successfully.

o Important investments were made in new markets, primarily

in Asia.

-0-

The global market's demand for Elekta's products continued to show strong growth. A positive trend was maintained in the company's most important markets, the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and Asia, which contributed to the Group's strong gains in sales and earnings during the first six months of the fiscal year.

Sales

Consolidated revenues of the Elekta Elekta, is a Swedish medical systems company founded by Lars Leksell, supplying neurosurgery, radiosurgery, radiotherapy, and magneto-encephalography equipment. History  Group rose by SEK 83.6 million to SEK 311.3 million (227.6)(a), or by 37 percent compared with the corresponding period of 1993. Elekta's growth is attributable primarily to the introduction of new products and higher sales volume for a number of product groups. Exchange rate fluctuations had only a marginal affect on the growth in sales and earnings during the period.

The Gamma Knife Gamma Knife

A trademark for a radiologic nonsurgical device used in stereotactic radiosurgery.


Gamma knife
A surgical tool that focuses beams of radiation at the head, which converge in the brain to form a lesion.
 was sold during the period in Asia, the U.S. and Europe Europe (yr`əp), 6th largest continent, c.4,000,000 sq mi (10,360,000 sq km) including adjacent islands (1992 est. pop. 512,000,000). . Interest in the company's products is considerable, particularly in Asia. The introduction of equipment for magnetic encephalography encephalography /en·ceph·a·log·ra·phy/ (en-sef?ah-log´rah-fe) radiography demonstrating the intracranial fluid-containing spaces after the withdrawal of cerebrospinal fluid and introduction of air or other gas; it includes  (MEG Shorthand for "mega." For example, 10 megs means 10 megabytes. It generally refers to bytes, not bits. See mega.

Meg

(Maggie) Tam O’Shanter’s gray mare that lost her tail to the witch. [Scot.
) has been successful and several orders were received in Japan during 1994.

The stereotactic stereotactic /ster·eo·tac·tic/ (-tak´tik)
1. characterized by precise positioning in space; said especially of discrete areas of the brain that control specific functions.

2. pertaining to stereotactic surgery.
 and imaged-based systems product area experienced favorable fa·vor·a·ble  
adj.
1. Advantageous; helpful: favorable winds.

2. Encouraging; propitious: a favorable diagnosis.

3.
 growth, in part through the market introduction of new products such as the Viewing Wand Viewing Wand® Imaging An intraoperative neurosurgical imaging device for head & neck procedures, and for spinal surgery .

Progress has been very positive for the newly established U.S. subsidiary Precision Therapy Inc. in Miami. This company supplies software and instruments for cancer treatment and quality assurance in cancer therapy. Revenues exceeded SEK 30 million during the year's first six months and the company expects to turn in a profit in its first full operating year. -0-

(a) Figures in parentheses See parenthesis.

parentheses - See left parenthesis, right parenthesis.
 refer to corresponding amounts for the period May 1 - October October: see month.  31, 1993.

The total order backlog Backlog

The total value of sales orders waiting to be fulfilled.

Notes:
This figure is used mainly in the manufacturing industry. Increases or decreases in a company's backlog indicate the future direction of sales and earnings.
 for the Elekta Group as of Oct. 31, 1994 amounted to SEK 186 million.

Operating expenses Operating expenses

The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted.


Operating expenses amounted to SEK 268.3 million (207.1). Significant investments were made during the period, most notably in sales and marketing and in research and development. Offices were established and new operations are being set up in Japan, China, India India, officially Republic of India, republic (2005 est pop. 1,080,264,000), 1,261,810 sq mi (3,268,090 sq km), S Asia. The second most populous country in the world, it is also sometimes called Bharat, its ancient name. India's land frontier (c.  and the U.S. The rate of increase in expenses has been lower than the growth in revenues thanks to a drop in the cost of materials and efforts to raise operating efficiency.

Earnings

Operating income Operating Income

The profit realized from a business' own operations.

Notes:
This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit.
 after depreciation amounted to SEK 34.2 million (15.2), an increase of 125 percent. The operating margin Operating Margin

A ratio used to measure a company's pricing strategy and operating efficiency.

Calculated by:
 thereby improved from 6.7 percent to 11.0 percent.

Net financial income and expenses were affected negatively by unrealized interest losses on an investment in a long-term Long-term

Three or more years. In the context of accounting, more than 1 year.


long-term

1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term.
 interest fund which decreased in value due to the rise in interest rates. The loss has been offset, however, by interest income on other short-term Short-term

Any investments with a maturity of one year or less.


short-term

1. Of or relating to a gain or loss on the value of an asset that has been held less than a specified period of time.
 investments.

Income before taxes amounted to SEK 35.0 million (19.0), corresponding to an increase of 84 percent. The profit margin rose by 2.9 percentage points to 11.2 percent.

Net income for the period amounted to SEK 29.4 million (15.6), an increase of 88 percent.

Order intake and thereby results can vary during the year primarily due to varying purchase patterns in the health care sector in different countries.

Earnings per share

Earnings after taxes as a ratio of the average weighted number of shares were SEK 3.98 (2.74), an increase of 45 percent. The weighted number of shares rose by 31 percent for comparable periods. For the full-year 1993/94, earnings amounted to SEK 8.05 per share after deducting SEK 1.60 for a non-recurring gain. In evaluating the rate of growth in earnings per share, notice should be taken of the increase in the number of shares.

Investments

Investments amounted to SEK 24.4 million (6.2) during the period and pertained primarily to new establishments. In addition, 8 percent of the shares of Surgical Technology Group, Ltd., UK was acquired during the period.

Liquidity and financial position

Liquid funds amounted to SEK 206.4 million (75.6). The company's financial position is very strong. The ratio of interest-bearing Adj. 1. interest-bearing - of financial obligations on which interest is paid  liabilities to shareholders' equity Shareholders' Equity

A firms' total assets minus its total liabilities. Equivalently, it is share capital plus retained earnings minus treasury shares. Shareholders' equity is the amount by which a company is financed through common and preferred shares.
 is less than 5 percent.

Share capital

As of Oct. 1, 1994, all of the outstanding options held by employees and shareholders had been exercised and 500,000 new Class B shares were issued. The proceeds to the company amounted to SEK 21.8 million (net). The number of the company's shares subsequently amounts to 7,897,180, or 7,689,000 as a weighted average for the full-year 1994/95, against a weighted average of 5,980,000 for the full-year 1993/94. This corresponds to an increase of 29 percent.

Parent Company

The Parent Company's revenues amounted to SEK 107.6 million (41.1) and its income before taxes was SEK 4.8 million (8.4) for the period.

Forecast for 1994/95

Elekta's growth and profitability are expected to be strong during the remainder of the fiscal year. Sales and earnings are expected to well exceed last year's levels.

Financial reports 1995

The preliminary report for fiscal 1994/95 will be released on June 20, 1995 and the Annual General Meeting will be held on Sept. 20, 1995. (Please note the new date!) -0-
                           Elekta AB
          Consolidated Income Statement (SEK Million)

                       1994              1993              1993/94
                  May 1 - Oct. 31   May 1 - Oct. 31   May 1 - April 30
                     (6 months)        (6 months)        (12 months)

Revenues                 311                227                506
Operating expenses       268                207                444

Operating Income
 before depreciation      43                 20                 62

Depreciation               9                  5                 12

Operating income
 after depreciation       34                 15                 50

Share in earnings
 of associated
 companies                 0                  2                  2
Financial income and
 expenses                  1                  2                 12

Income after
 financial items          35                 19                 64

Taxes                      5                  3                  6

Net income                30                 16                 58


Consolidated Balance Sheet
 (SEK Million)

                            Oct. 31,      Oct. 31,        April 30
                              1994          1993            1994
Assets
Cash and cash equivalents     206            76             186
Other current assets          303           256             267
Fixed assets                   99            74              82

Total assets                  608           406             535

Liabilities and
 shareholders' equity
Current liabilities           129           190             104
Long-term liabilities          22            29              23
Shareholders' equity          457           187             408

Total liabilities and
 shareholders' equity         608           406             535


Key Financial Ratios

                       1994              1993              1993/94
                  May 1 - Oct. 31   May 1 - Oct. 31   May 1 - April 30
                     (6 months)        (6 months)        (12 months)

Operating margin, %     11,0             6,7                9,9
Profit margin,
 before taxes, %        11,2             8,3               12,7
Per-share data:
 Earnings after
  taxes, SEK            3:98             2:74              8:05(a)
 Shareholders'
  equity, SEK          57:87            32:82             55:10
 Average number
  of shares (000s)     7 481            5 697             5 980
 Number of shares
  at end of period
  (000s)               7 897            5 697             7 397

(a) Reduced by SEK 1.60 for non-recurring revenue

EDITOR'S NOTE:  As of December 12, 1994, US$1 equals 7.5 SEK.

Stockholm, December 13, 1994

Elekta AB

Laurent Leksell
President

Audit Report

We have reviewed this interim report and in doing so followed the
recommendation of the Swedish Institute of Authorized Public
Accountants (FAR).  A review as such is considerably limited in
comparison with a full-fledged audit.  There have been no
indications that this interim report does not comply with the
requirements of Swedish stock market and company law.

Stockholm, December 13, 1994

Coopers & Lybrand AB

Lennart Danielsson                      Dennis Svensson
Authorized Public Accountant            Authorized Public Accountant


CONTACT: Elekta AB, Stockholm
              Sverker Littorin, 011-46-8-402-5400
                       or
              The Anne McBride Company Inc., New York
              Robert Rinderman, 212/752-0504
COPYRIGHT 1994 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 13, 1994
Words:1298
Previous Article:NEGOTIATIONS BETWEEN RECOTON AND NAKI ELECTRONICS HAVE ENDED.
Next Article:Mid-America Apartment Communities completes acquisitions.
Topics:



Related Articles
Elekta acquires Cordis Neuroscience Business from Johnson & Johnson.
Elekta AB - publ - Interim Report for the Three Months Ended July 31, 2001.
Elekta AB -Publ- Interim Report for the Six Months Ended October 31, 2001.
Elekta AB -publ- Interim Report for the Nine Months Ended January 31, 2002.
ELEKTA AB -- publ -- Report on Operations for the Fiscal Year Ended April 30, 2002.
Elekta AB : Interim Report for the Three-Months Ended July 31, 2002.
Elekta's Annual General Meeting 2002.
ELEKTA AB: Interim Report for the Six-Month Period May 1 Through October 31, 2002.
SEOUL HOSPITAL SELECTS ELEKTA MEG EQUIPMENT.
ELEKTA Annual General Meeting 2006.(Company overview)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles